Stueland Katherine bought WGS
March 15, 2026 · Form 4 insider transaction
Stueland Katherine bought 11,921 shares of GeneDx Holdings Corp. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,921
Price
$0.00
Total value
N/A
InsiderStueland Katherine
RoleOfficer, Director
CompanyGeneDx Holdings Corp. (WGS)
SecurityClass A Common Stock
Transaction codeM: Option exercise
Transaction dateMarch 15, 2026
Filing dateMarch 17, 2026
Shares owned after56,876
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.